Related Experiment Video

Updated: Aug 16, 2026

Homogeneous Glycoconjugate Produced by Combined Unnatural Amino Acid Incorporation and Click-Chemistry for Vaccine Purposes
13:53

Homogeneous Glycoconjugate Produced by Combined Unnatural Amino Acid Incorporation and Click-Chemistry for Vaccine Purposes

Published on: December 19, 2020

[Conjugated vaccines]

Bernard Fritzell1

  • 1International Scientific & Clinical Affairs, Wyeth Vaccines, La Défense, Paris, France. fritzeb@wyeth.com

Therapie
|September 1, 2005
PubMed

Insights

Conjugate vaccines protect infants from encapsulated bacterial pathogens like Hib and pneumococcus by converting T-independent antigens into T-dependent ones, significantly reducing invasive diseases and providing herd protection.

Area of Science:

  • Immunology
  • Vaccinology
  • Microbiology

Context:

  • Infants and young children are vulnerable to encapsulated bacterial pathogens due to waning maternal antibodies and immature immune systems.
  • Polysaccharide capsules of bacteria like Haemophilus influenzae type b (Hib), Neisseria meningitidis, and Streptococcus pneumoniae are T-independent antigens, poorly immunogenic in young children.

Purpose:

  • To explain the mechanism of polysaccharide-protein conjugate vaccines in overcoming the immunodeficiency in infants against encapsulated bacteria.
  • To highlight the public health impact of conjugate vaccines in reducing invasive bacterial diseases.

Summary:

  • Conjugate vaccines convert bacterial polysaccharide antigens into T-dependent antigens by linking them to carrier proteins.
  • This conversion enables infants to mount a robust T-cell dependent immune response, leading to protective immunity.
  • Vaccination with conjugate vaccines has dramatically reduced the incidence of invasive diseases caused by Hib, meningococcus, and pneumococcus.

Impact:

  • Conjugate vaccines have led to an over 80% reduction in invasive diseases caused by targeted pathogens, representing a major public health achievement.
  • These vaccines confer 'herd protection' by reducing nasopharyngeal colonization in vaccinated children, thereby protecting unvaccinated individuals.
  • Future research focuses on expanding the serogroups targeted by meningococcal and pneumococcal conjugate vaccines to broaden protection.

More Related Videos

Chemical Conjugation of a Purified DEC-205-Directed Antibody with Full-Length Protein for Targeting Mouse Dendritic Cells In Vitro and In Vivo10:35

Chemical Conjugation of a Purified DEC-205-Directed Antibody with Full-Length Protein for Targeting Mouse Dendritic Cells In Vitro and In Vivo

Published on: February 5, 2021

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches13:36

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches

Published on: May 6, 2015

Related Concept Videos

Conjugated Proteins02:50

Conjugated Proteins

Simple proteins and protein complexes contain only amino acids. In contrast, many other proteins, called conjugated proteins, covalently bond with non-protein moieties.
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
Conjugated Proteins02:50

Conjugated Proteins

Simple proteins and protein complexes contain only amino acids. In contrast, many other proteins, called conjugated proteins, covalently bond with non-protein moieties.
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Vaccinations01:51

Vaccinations

Overview
Vaccines01:21

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
Vaccine Production01:23

Vaccine Production

Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...